Russell AS, Sturge RA, Smith MA. Serum transaminases during salicylate therapy.
BRITISH MEDICAL JOURNAL 1971;
2:428-9. [PMID:
5576002 PMCID:
PMC1796143 DOI:
10.1136/bmj.2.5759.428]
[Citation(s) in RCA: 63] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
Abstract
In 8 out of 32 juvenile patients suffering from chronic polyarthritis and in one patient with dermatomyositis, raised transaminase levels were found; the salicylate level was above 35 mg/100 ml in all except one. Reduction in the salicylate level led to a prompt fall in the serum transaminases. Despite a rise in alkaline phosphatase in three cases there was no other evidence of liver dysfunction in the children. Only one of the adults showed a rise in transaminase levels, and she had mild cirrhosis.
Collapse